KCF advised Lysogene on the raising of venture debt from the European Investment Bank (EIB)

January 2022

KCF acted as exclusive financial advisor to Lysogene in connection with the raising of an unsecured venture loan from the EIB.

Lysogene was founded in 2009 and develops new treatments against rare and genetic diseases affecting the central nervous system.